BT accelerates the degradation of GPX4, elevates intracellular Fe2+ levels, induces ferroptosis and lipid peroxidation, and thereby inhibits the proliferation of NSCLC cells [83]. The gene discussed is GPX4; the disease is non-small cell lung carcinoma.